secwatch.observer — SEC 8-K summary
======================================

Issuer:     WEST PHARMACEUTICAL SERVICES INC (WST)
CIK:        0000105770
Form:       8-K
Filed at:   2025-07-21T23:59:59+00:00
Accession:  0000105770-25-000058
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

West Pharma names Robert McMahon CFO effective Aug 4; Birkett to advise
-----------------------------------------------------------------------

- McMahon to receive $800k base salary, target bonus 80% of base, LTI award of $3M on Aug 11.
- One-time cash sign-on bonus of $3.115M and replacement equity grant of $4.2M for forfeited prior comp.
- McMahon previously CFO at Agilent (2018-2025) and Hologic; 20 years at Johnson & Johnson.
- Outgoing CFO Bernard Birkett will serve as Senior Advisor to CEO through Dec 31, 2025 for transition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/105770/000010577025000058/0000105770-25-000058-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/105770/000010577025000058/wst-20250721.htm
  HTML page:      https://secwatch.observer/filing/0000105770-25-000058

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer